Insider Trading activities at Biomarin Pharmaceutical Inc (BMRN) , Part 6

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biomarin Pharmaceutical Inc (BMRN) since 2005 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biomarin Pharmaceutical Inc. (See page 1 of this report.) Table 2 shows the detailed insider transactions. This company's CIK number is 1048477.

Total stock buying since 2005: $2,433,737.
Total stock sales since 2005: $583,535,292.
Total stock option exercises since 2005: $188,288,866.


28 insiders reported insider trading activities at Biomarin Pharmaceutical Inc (BMRN):
Insider trading activities of Slamon Dennis
Insider trading activities of Aselage Steve
Insider trading activities of Swiedler Stuart J
Insider trading activities of Cooper Jeffrey H
Insider trading activities of Heron Elaine J
Insider trading activities of Starr Christopher M
Insider trading activities of Spiegelman Daniel K
Insider trading activities of Bienaime Jean Jacques
Insider trading activities of Ajer Jeffrey Robert
Insider trading activities of Lewis Alan
Insider trading activities of Davis George Eric
Insider trading activities of Mueller Brian
Insider trading activities of Lapalme Pierre
Insider trading activities of Klein Joseph Iii
Insider trading activities of Hubbard Cristin
Insider trading activities of Guyer Charles Greg
Insider trading activities of Dere Willard H
Insider trading activities of Lawlis V Bryan
Insider trading activities of Sager Erich
Insider trading activities of Kakkis Emil D
Insider trading activities of Grey Michael G
Insider trading activities of Burkhart Erin
Insider trading activities of Fuchs Henry J
Insider trading activities of Alles Mark J
Insider trading activities of Meier Richard A
Insider trading activities of Baffi Robert
Insider trading activities of Wood Mark
Insider trading activities of Pyott David E I

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Biomarin Pharmaceutical Inc (BMRN).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 11,732 $809,525 0 $0
2024 0 $0 255,921 $21,765,611 199,347 $12,744,795
2023 0 $0 291,124 $29,165,285 298,974 $20,261,651
2022 3,625 $314,468 311,275 $27,255,098 253,242 $11,640,873
2021 0 $0 191,799 $15,370,940 178,931 $4,916,104
2020 12,800 $1,005,145 360,561 $39,226,570 301,650 $13,887,132
2019 0 $0 186,014 $16,384,008 131,953 $2,232,548
2018 0 $0 443,177 $39,824,783 396,390 $13,170,758
2017 0 $0 308,037 $28,193,855 265,930 $7,893,265
2016 0 $0 1,279,525 $111,508,495 1,208,448 $28,339,513
2015 0 $0 411,289 $48,410,265 295,446 $6,663,831
2014 0 $0 340,526 $26,836,672 306,781 $7,721,726
2013 0 $0 742,342 $47,391,614 730,412 $15,099,577
2012 0 $0 1,247,954 $51,415,184 1,198,637 $17,833,395
2011 0 $0 332,106 $9,638,946 335,054 $4,369,131
2010 800 $16,062 564,962 $13,310,700 545,102 $7,510,310
2009 26,500 $306,434 74,572 $1,277,220 83,753 $455,350
2008 16,752 $218,171 1,172,420 $39,560,526 973,113 $8,505,589
2007 17,587 $107,335 576,356 $12,583,816 477,563 $3,277,058
2006 35,493 $362,571 184,500 $2,780,052 284,500 $1,766,260
2005 12,000 $103,551 81,142 $826,127 0 $0


Table 3. Detailed insider trading at Biomarin Pharmaceutical Inc (BMRN) , Part 6
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2013-11-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2013-11-01 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 99 63.16 6,252
2013-10-31 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 62.72 627,160
2013-10-31 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 12.99 129,900
2013-10-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 67.72 135,450
2013-10-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2013-10-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 66.76 200,292
2013-09-19 Fuchs Henry J (EVP, Chief Medical Officer) Sale 10,000 80.19 801,900
2013-09-19 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 10,000 11.05 110,500
2013-09-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 73.08 146,164
2013-09-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2013-09-09 Baffi Robert (EVP, Technical Operations) Sale 20,000 73.00 1,460,000
2013-09-09 Baffi Robert (EVP, Technical Operations) Option Ex 20,000 21.51 430,200
2013-09-05 Fuchs Henry J (EVP, Chief Medical Officer) Sale 10,000 70.00 700,000
2013-09-05 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 10,000 11.05 110,500
2013-09-04 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 9,000 69.00 621,000
2013-09-04 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 9,000 39.06 351,540
2013-08-15 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 64.36 64,364
2013-08-15 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,000 12.99 12,990
2013-07-15 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 38.34 76,688
2013-07-01 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 4,066 59.78 243,061
2013-07-01 Fuchs Henry J (EVP, Chief Medical Officer) Sale 10,000 60.00 600,000
2013-07-01 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 10,000 11.05 110,500
2013-06-12 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2013-06-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 20,000 43.89 877,800
2013-06-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 20,000 36.85 737,099
2013-06-03 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 493 58.34 28,763
2013-06-03 Fuchs Henry J (EVP, Chief Medical Officer) Sale 1,098 58.32 64,036
2013-05-31 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 12.99 38,970
2013-05-23 Fuchs Henry J (EVP, Chief Medical Officer) Sale 8,710 67.16 584,981
2013-05-22 Wood Mark (VP, Human Resources) Sale 3,103 67.12 208,282
2013-05-22 Wood Mark (VP, Human Resources) Option Ex 3,103 24.96 77,457
2013-05-22 Fuchs Henry J (EVP, Chief Medical Officer) Sale 11,899 65.66 781,240
2013-05-22 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 10,000 11.05 110,500
2013-05-21 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 64.14 128,277
2013-05-21 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2013-05-17 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 64.01 320,050
2013-05-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 64.65 129,306
2013-05-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 7,000 38.82 271,754
2013-05-15 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 68.55 685,480
2013-05-15 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 12.99 129,900
2013-05-14 Mueller Brian (VP, Corporate Controller) Sale 4,947 70.37 348,130
2013-05-14 Mueller Brian (VP, Corporate Controller) Option Ex 3,500 21.51 75,285
2013-05-14 Davis George Eric (SVP, General Counsel) Sale 20,000 70.34 1,406,800
2013-05-14 Davis George Eric (SVP, General Counsel) Option Ex 20,000 21.51 430,200
2013-05-14 Baffi Robert (EVP, Technical Operations) Sale 20,000 70.00 1,400,000
2013-05-14 Baffi Robert (EVP, Technical Operations) Option Ex 20,000 21.51 430,200
2013-05-14 Bienaime Jean Jacques (Chief Executive Officer) Sale 40,000 70.56 2,826,590
2013-05-14 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 40,000 12.99 519,600
2013-05-13 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 1,248 69.25 86,430
2013-05-13 Davis George Eric (SVP, General Counsel) Sale 2,590 69.29 179,453
2013-05-13 Bienaime Jean Jacques (Chief Executive Officer) Sale 15,000 68.98 1,034,640
2013-05-13 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 8,000 12.99 103,920
2013-05-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 800 67.48 53,984
2013-05-09 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 811 66.00 53,528
2013-05-08 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 65.88 65,879
2013-05-07 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 65.87 197,612
2013-05-07 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 12.99 38,970
2013-05-03 Mueller Brian (VP, Corporate Controller) Sale 7,500 67.11 503,294
2013-05-03 Mueller Brian (VP, Corporate Controller) Option Ex 7,500 21.51 161,325
2013-05-03 Davis George Eric (SVP, General Counsel) Sale 5,854 67.19 393,324
2013-05-03 Davis George Eric (SVP, General Counsel) Option Ex 5,854 15.96 93,459
2013-05-03 Baffi Robert (EVP, Technical Operations) Sale 20,000 67.00 1,340,000
2013-05-03 Baffi Robert (EVP, Technical Operations) Option Ex 20,000 14.39 287,800
2013-05-03 Bienaime Jean Jacques (Chief Executive Officer) Sale 8,000 67.24 537,896
2013-05-03 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 8,000 12.99 103,920
2013-05-02 Mueller Brian (VP, Corporate Controller) Sale 9,331 65.42 610,387
2013-05-02 Mueller Brian (VP, Corporate Controller) Option Ex 4,874 14.39 70,136
2013-05-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 65.62 131,240
2013-05-02 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2013-05-01 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 797 64.52 51,420
2013-05-01 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 28,000 64.42 1,803,900
2013-05-01 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 28,000 39.06 1,093,680
2013-04-30 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 63.74 63,742
2013-04-30 Fuchs Henry J (EVP, Chief Medical Officer) Sale 20,000 63.29 1,265,800
2013-04-30 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 20,000 11.05 221,000
2013-04-22 Wood Mark (VP, Human Resources) Sale 3,102 65.58 203,413
2013-04-22 Wood Mark (VP, Human Resources) Option Ex 3,102 24.96 77,432
2013-04-19 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 5,000 65.00 325,000
2013-04-19 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Option Ex 5,000 21.51 107,550
2013-04-10 Baffi Robert (EVP, Technical Operations) Sale 20,000 64.00 1,280,000
2013-04-10 Baffi Robert (EVP, Technical Operations) Option Ex 20,000 14.39 287,800
2013-03-26 Bienaime Jean Jacques (Chief Executive Officer) Sale 12,000 60.68 728,148
2013-03-26 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 12,000 12.99 155,880
2013-03-22 Wood Mark (VP, Human Resources) Sale 3,103 60.21 186,822
2013-03-22 Wood Mark (VP, Human Resources) Option Ex 3,103 24.96 77,457
2013-03-18 Baffi Robert (EVP, Technical Operations) Sale 20,000 61.02 1,220,360
2013-03-18 Baffi Robert (EVP, Technical Operations) Option Ex 20,000 14.39 287,800
2013-03-06 Grey Michael G Sale 15,000 60.61 909,135
2013-03-04 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 4,000 60.00 240,000
2013-03-04 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Option Ex 4,000 21.51 86,040
2013-03-04 Davis George Eric (SVP, General Counsel) Sale 4,000 60.18 240,724
2013-03-04 Davis George Eric (SVP, General Counsel) Option Ex 4,000 17.86 71,440
2013-03-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 60.00 300,000
2013-03-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2013-03-03 Grey Michael G Option Ex 15,000 14.39 215,850
2013-03-01 Mueller Brian (VP, Corporate Controller) Sale 7,038 59.77 420,682
2013-03-01 Mueller Brian (VP, Corporate Controller) Option Ex 5,023 23.61 118,608
2013-03-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 59.14 59,140
2013-02-28 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 58.00 290,000
2013-02-28 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2013-02-27 Davis George Eric (SVP, General Counsel) Sale 8,000 56.90 455,184
2013-02-27 Davis George Eric (SVP, General Counsel) Option Ex 8,000 15.96 127,720
2013-02-27 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 56.46 84,684
2013-02-27 Lewis Alan Sale 22,500 56.57 1,272,757
2013-02-27 Lewis Alan Option Ex 22,500 24.83 558,675
2013-02-26 Lapalme Pierre Sale 29,900 55.34 1,654,785
2013-02-26 Lapalme Pierre Option Ex 29,900 9.81 293,319
2013-02-22 Wood Mark (VP, Human Resources) Sale 3,103 55.13 171,071
2013-02-22 Wood Mark (VP, Human Resources) Option Ex 3,103 24.96 77,457
2013-02-19 Meier Richard A Sale 5,000 57.50 287,500
2013-02-19 Meier Richard A Option Ex 5,000 16.92 84,600
2013-02-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,000 55.77 111,532
2013-02-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 2,000 12.99 25,980
2013-01-23 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 55.22 220,880
2013-01-22 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 3,000 55.00 165,000
2013-01-22 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Option Ex 3,000 21.51 64,530
2013-01-22 Wood Mark (VP, Human Resources) Sale 46,749 54.91 2,566,753
2013-01-22 Wood Mark (VP, Human Resources) Option Ex 46,749 27.69 1,294,386
2013-01-22 Baffi Robert (EVP, Technical Operations) Sale 19,575 55.00 1,076,625
2013-01-22 Baffi Robert (EVP, Technical Operations) Option Ex 19,575 17.54 343,345
2013-01-22 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 55.00 550,000
2013-01-18 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 54.00 270,000
2013-01-18 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2013-01-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 52.24 156,732
2013-01-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 12.99 38,970
2013-01-03 Baffi Robert (EVP, Technical Operations) Sale 20,000 53.00 1,060,000
2013-01-03 Baffi Robert (EVP, Technical Operations) Option Ex 20,000 17.54 350,800
2013-01-02 Meier Richard A Sale 10,000 51.25 512,500
2013-01-02 Meier Richard A Option Ex 10,000 16.92 169,200
2012-12-31 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 48.62 243,115
2012-12-31 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2012-12-27 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 48.34 193,360
2012-12-27 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 12.99 51,960
2012-12-26 Bienaime Jean Jacques (Chief Executive Officer) Sale 7,000 48.38 338,632
2012-12-26 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 7,000 12.99 90,930
2012-12-24 Bienaime Jean Jacques (Chief Executive Officer) Sale 6,000 48.38 290,250
2012-12-24 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 6,000 12.99 77,940
2012-12-21 Bienaime Jean Jacques (Chief Executive Officer) Sale 9,000 48.57 437,139
2012-12-21 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 9,000 12.99 116,910
2012-12-17 Wood Mark (VP, Human Resources) Sale 2,756 49.32 135,925
2012-12-17 Wood Mark (VP, Human Resources) Option Ex 2,756 20.06 55,293
2012-12-13 Wood Mark (VP, Human Resources) Sale 7,659 49.11 376,156
2012-12-12 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 50.00 250,000
2012-12-12 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 12.99 64,950
2012-12-11 Meier Richard A Sale 5,000 49.71 248,560
2012-12-11 Meier Richard A Option Ex 5,000 16.92 84,600
2012-12-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 48.03 144,084
2012-12-10 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 3,000 12.99 38,970
2012-12-07 Bienaime Jean Jacques (Chief Executive Officer) Sale 3,000 47.04 141,123

Insider trading activities including stock purchases, stock sales, and option exercises of BMRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN, CIK number 1048477) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.